The debate on the appropriate treatment of patients with papillary thyroid cancer (PTC) has
persisted for several decades. The main controversies focus on the extent of surgery, the …

The treatment of papillary thyroid cancer is now based on individual patient risk and
response to therapies. Molecular techniques are increasingly being used to risk stratify and …

Opinion statement The incidence of thyroid cancer has been increasing over the past 30
years, and it is now the seventh most common cancer in women. Papillary thyroid cancer is …

Opinion statement Papillary thyroid cancer (PTC), the most common thyroid malignancy, is
associated with an excellent prognosis. Overall survival is more than 90%. The first-line …

Objective The goal of this article was to describe the optimal individualized surgical
management of patients with papillary thyroid cancer (PTC). Methods This summary reviews …

Opinion statement Papillary thyroid cancer is the most common neoplasm of the thyroid
gland. Surgical resection is the cornerstone of therapy. There is controversy regarding the …

The incidence of thyroid cancer is increasing by 4% per year. Thyroid cancer has become
the eighth most common malignancy diagnosed in women. Papillary cancer accounts for …

The surgical management of papillary thyroid carcinoma remains contentious and the
optimal surgical strategy has not been yet established. The extent of thyroid resection has …

The papillary thyroid carcinoma (PTC) is the most frequent endocrine cancer and it is the
most common thyroid cancer (85-95%). Potential risk factors for the incidence of the PTC …

Multiple prognostic factors for outcome in papillary thyroid carcinoma are identified. For a
cohort of 1500 consecutive patients followed an average of 16 years, survival rates for tumor …